Provide synthesis of the synthetic form of preimplantation factor (spif) drug study.
Ended Purchase Order Awarded Last action
- Contract number
- HT942524P0157
- Awardee
-
Bioincept LLC UEI FHUHJETDV881
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $58,000
Award facts
- Opportunity
-
- Notice of Intent to Sole Source Synthetic Preimplantation Factor (sPIF) Special Notice · HT942524Q0097 · Posted Jul 11, 2024
- Contract value 33% obligated
-
- $58,000.00 Current, with exercised options
- $174,000.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20910, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $174,000 firm fixed-price purchase order to Bioincept LLC on September 25, 2024, for the synthesis and provision of Preimplantation Factor (sPIF) to support the Walter Reed Army Institute of Research's Blast Induced Neurotrauma Branch. The work will be performed in Silver Spring, Maryland, with an ultimate completion date of September 24, 2027. This non-competitive award was issued following a special notice that identified Bioincept LLC as the sole source capable of developing and synthesizing the required sPIF compound, as the product is proprietary to the contractor and unavailable through alternative suppliers.
The contract supports WRAIR's scientific research into the efficacy of synthetic Preimplantation Factor as a potential therapeutic intervention for blast-induced neurotrauma. The underlying special notice, posted on July 11, 2024, with a response deadline of July 26, 2024, allowed interested parties to demonstrate alternative capabilities; however, no competing sources were identified. This sole-source procurement is typical for specialized pharmaceutical or biochemical products where intellectual property and technical expertise are concentrated with a single vendor. The award reflects the Defense Health Agency's commitment to advancing medical research initiatives under the Department of Defense's medical research portfolio.
Quick answers
Who was awarded contract HT942524P0157?
HT942524P0157 was awarded to Bioincept LLC by Defense Health Agency (Department of Defense) on September 25, 2024.
How much is contract HT942524P0157 worth?
The government has obligated $58,000 on HT942524P0157. Its potential value, with all options, is $174,000.
Was contract HT942524P0157 competed?
The extent of competition for HT942524P0157 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award